{
  "links": "https://www.ycombinator.com/companies/microhealth",
  "name": "MicroHealth",
  "headline": "Digital hematology",
  "batch": "S15",
  "description": "What we do?\r\n\nWe develop digital therapeutics to address unmet medical needs in hematology and oncology. \r\n\nHow it works?\r\n\nFirst we build networks of doctors and patients designed to track, predict and prevent disease. Second, we validate the safety and efficacy of our interventions in pivotal clinical studies to obtain regulatory clearance (SaMD). Finally, we aim to commercialize our products as prescription digital therapeutics (DTx).\r\n\nWhere are we now?\r\n\nToday, we are the standard in digital hematology:\r\n\n* Our hemophilia network covers 33% of all patients and providers in the US. \r\n* We bested 20+ competitors, including several Fortune 500 companies. \r\n* Our clients include: Sanofi, Bayer, Novo Nordisk, Biogen, and Roche.",
  "activity_status": "Active",
  "website": "http://microhealth.com",
  "founded_date": 2015.0,
  "team_size": 10.0,
  "location": "New York",
  "group_partner": null,
  "group_partner_yc": null,
  "company_linkedin": null,
  "company_twitter": null,
  "tags": "industry:digital-health; industry:healthcare; location:new-york",
  "founders": [
    {
      "name": "Marc Lara, Founder",
      "description": "Expert indigital health, including:\n- Launching products for new therapeutic areas \n- Improving health outcomes\n- Clinical and HEOR studies\n- Domestic and global deployments \n- Predictive AI for medical and commercial goals",
      "linkedin": "linkedin.com/mlaranyc"
    },
    {
      "name": "Miguel Lara, Founder/CEO",
      "description": "● 10+ years as Digital Health startup CEO\n● Deep relationships across the biopharma ecosystem\n● 10+ years as Managing Director (healthcare) at global bank\n● Y Combinator (YC_S15) alumni",
      "linkedin": "http://linkedin.com/in/mlara1/en"
    }
  ],
  "status": true,
  "markdown": "raw_markdown='[ ![](https://microhealth.com/wp-content/uploads/2020/07/Frame.svg) ](http://microhealth.com/<https:/microhealth.com>)\\n  * Products \\n![](https://microhealth.com/wp-content/themes/microhealth/assets/icons/patients.svg)\\n## For Patients\\n    * Hemophilia [iOS](http://microhealth.com/<https:/apps.apple.com/app/microhealth-hemophilia/id816380822>) | [Android](http://microhealth.com/<https:/play.google.com/store/apps/details?id=com.microhealth.hemophilia>)\\n    * Sickle Cell Disease [iOS](http://microhealth.com/<https:/apps.apple.com/app/scd-warrior/id1587853117>) | [Android](http://microhealth.com/<https:/play.google.com/store/apps/details?id=com.scdwarrior>)\\n    * Blood Cancers: Coming Soon | \\n![](https://microhealth.com/wp-content/themes/microhealth/assets/icons/providers.svg)\\n## For Providers\\n    * [Hemophilia](http://microhealth.com/<https:/microhealth.org/account/sign_up>)\\n    * [Sickle Cell Disease](http://microhealth.com/<https:/scdwarrior.com/hcp/>)\\n    * [Blood Cancers: Coming Soon](http://microhealth.com/<https:/microhealth.com/coming-soon/>)\\n![](https://microhealth.com/wp-content/themes/microhealth/assets/icons/biopharma.svg)\\n## For Pharma\\n    * [Engagement & Adherence](http://microhealth.com/<https:/microhealth.com/products/adherence-outreach/>)\\n    * [Research & Study Support](http://microhealth.com/<https:/microhealth.com/products/research-studies/>)\\n    * [AI Algorithms & Interventions](http://microhealth.com/<https:/microhealth.com/products/algorithms-interventions/>)\\n\\n\\n  * [Privacy](http://microhealth.com/<https:/microhealth.com/privacy/>)\\n  * [About](http://microhealth.com/<https:/microhealth.com/about-us/>)\\n  * [Publications](http://microhealth.com/<https:/microhealth.com/science/>)\\n  * [Blog](http://microhealth.com/<https:/microhealth.com/microhealth-blog/>)\\n\\n\\nLogin ![dropdown icon](https://microhealth.com/wp-content/themes/microhealth/assets/icons/chevron-down.svg)\\n  * [Hemophilia](http://microhealth.com/<https:/microhealth.org/account/sign_up>)\\n  * [Sickle Cell Disease](http://microhealth.com/<https:/scdwarrior.com/hcp/>)\\n  * [Blood Cancers: Coming Soon](http://microhealth.com/<https:/microhealth.com/coming-soon/>)\\n\\n\\n  * Products\\nFor Patients\\n    * Hemophilia [iOS](http://microhealth.com/<https:/apps.apple.com/app/microhealth-hemophilia/id816380822>) | [Android](http://microhealth.com/<https:/play.google.com/store/apps/details?id=com.microhealth.hemophilia>)\\n    * Sickle Cell Disease [iOS](http://microhealth.com/<https:/apps.apple.com/app/scd-warrior/id1587853117>) | [Android](http://microhealth.com/<https:/play.google.com/store/apps/details?id=com.scdwarrior>)\\n    * Blood Cancers: Coming Soon | \\nFor Providers\\n    * [Hemophilia](http://microhealth.com/<https:/microhealth.org/account/sign_up>)\\n    * [Sickle Cell Disease](http://microhealth.com/<https:/scdwarrior.com/hcp/>)\\n    * [Blood Cancers: Coming Soon](http://microhealth.com/<https:/microhealth.com/coming-soon/>)\\nFor Pharma\\n    * [Engagement & Adherence](http://microhealth.com/<https:/microhealth.com/products/adherence-outreach/>)\\n    * [Research & Study Support](http://microhealth.com/<https:/microhealth.com/products/research-studies/>)\\n    * [AI Algorithms & Interventions](http://microhealth.com/<https:/microhealth.com/products/algorithms-interventions/>)\\n\\n\\n  * [Privacy](http://microhealth.com/<https:/microhealth.com/privacy/>)\\n  * [About](http://microhealth.com/<https:/microhealth.com/about-us/>)\\n  * [Publications](http://microhealth.com/<https:/microhealth.com/science/>)\\n  * [Blog](http://microhealth.com/<https:/microhealth.com/microhealth-blog/>)\\n\\n\\n# We build digital tools for people living with blood conditions\\n[Learn More](http://microhealth.com/<#learn>)\\n#### How we do it\\n## The New Standard in Digital Hematology\\n![](http://microhealth.com/wp-content/uploads/2020/09/a0.png)\\n### Build\\nWe build networks of patients and doctors focused on Hem/Onc.\\n![](http://microhealth.com/wp-content/uploads/2020/09/graphic2-1.png)\\n### Track\\nWe track treatment events to help improve care and grow longitudinal data assets. \\n![](http://microhealth.com/wp-content/uploads/2020/09/Group-66.png)\\n### Predict\\nWe leverage real world data and predictive AI models to anticipate events.\\n![](http://microhealth.com/wp-content/uploads/2020/09/graphic4-1.png)\\n### Prevent\\nWe empower users with timely information to better manage disease.\\n#### Track Record\\n![](http://microhealth.com/wp-content/uploads/2020/06/chart.png)\\n## Our hemophilia network covers 33% of all prophylaxis patients and HTCs in the US\\n# Ask us anything\\n[Terms of Service](http://microhealth.com/<http:/microhealth.com/terms-of-service/>) and [Privacy Notice](http://microhealth.com/<http:/microhealth.com/privacy-notice/>)\\n© 2024 Microhealth, Inc. – All rights reserved\\n  * [](http://microhealth.com/<https:/www.facebook.com/MicroHealth/>)\\n  * [](http://microhealth.com/<https:/www.instagram.com/mymicrohealth/>)\\n  * [](http://microhealth.com/<https:/www.linkedin.com/company/microhealth/>)\\n\\n\\n' markdown_with_citations=' ![⟨1⟩ ](http://microhealth.com/<https:/microhealth.com>)\\n  * Products \\n![](https://microhealth.com/wp-content/themes/microhealth/assets/icons/patients.svg)\\n## For Patients\\n    * Hemophilia iOS⟨2⟩ | Android⟨3⟩\\n    * Sickle Cell Disease iOS⟨4⟩ | Android⟨5⟩\\n    * Blood Cancers: Coming Soon | \\n![](https://microhealth.com/wp-content/themes/microhealth/assets/icons/providers.svg)\\n## For Providers\\n    * Hemophilia⟨6⟩\\n    * Sickle Cell Disease⟨7⟩\\n    * Blood Cancers: Coming Soon⟨8⟩\\n![](https://microhealth.com/wp-content/themes/microhealth/assets/icons/biopharma.svg)\\n## For Pharma\\n    * Engagement & Adherence⟨9⟩\\n    * Research & Study Support⟨10⟩\\n    * AI Algorithms & Interventions⟨11⟩\\n\\n\\n  * Privacy⟨12⟩\\n  * About⟨13⟩\\n  * Publications⟨14⟩\\n  * Blog⟨15⟩\\n\\n\\nLogin ![dropdown icon⟨16⟩]\\n  * Hemophilia⟨6⟩\\n  * Sickle Cell Disease⟨7⟩\\n  * Blood Cancers: Coming Soon⟨8⟩\\n\\n\\n  * Products\\nFor Patients\\n    * Hemophilia iOS⟨2⟩ | Android⟨3⟩\\n    * Sickle Cell Disease iOS⟨4⟩ | Android⟨5⟩\\n    * Blood Cancers: Coming Soon | \\nFor Providers\\n    * Hemophilia⟨6⟩\\n    * Sickle Cell Disease⟨7⟩\\n    * Blood Cancers: Coming Soon⟨8⟩\\nFor Pharma\\n    * Engagement & Adherence⟨9⟩\\n    * Research & Study Support⟨10⟩\\n    * AI Algorithms & Interventions⟨11⟩\\n\\n\\n  * Privacy⟨12⟩\\n  * About⟨13⟩\\n  * Publications⟨14⟩\\n  * Blog⟨15⟩\\n\\n\\n# We build digital tools for people living with blood conditions\\nLearn More⟨17⟩\\n#### How we do it\\n## The New Standard in Digital Hematology\\n![](http://microhealth.com/wp-content/uploads/2020/09/a0.png)\\n### Build\\nWe build networks of patients and doctors focused on Hem/Onc.\\n![](http://microhealth.com/wp-content/uploads/2020/09/graphic2-1.png)\\n### Track\\nWe track treatment events to help improve care and grow longitudinal data assets. \\n![](http://microhealth.com/wp-content/uploads/2020/09/Group-66.png)\\n### Predict\\nWe leverage real world data and predictive AI models to anticipate events.\\n![](http://microhealth.com/wp-content/uploads/2020/09/graphic4-1.png)\\n### Prevent\\nWe empower users with timely information to better manage disease.\\n#### Track Record\\n![](http://microhealth.com/wp-content/uploads/2020/06/chart.png)\\n## Our hemophilia network covers 33% of all prophylaxis patients and HTCs in the US\\n# Ask us anything\\nTerms of Service⟨18⟩ and Privacy Notice⟨19⟩\\n© 2024 Microhealth, Inc. – All rights reserved\\n  * [](http://microhealth.com/<https:/www.facebook.com/MicroHealth/>)\\n  * [](http://microhealth.com/<https:/www.instagram.com/mymicrohealth/>)\\n  * [](http://microhealth.com/<https:/www.linkedin.com/company/microhealth/>)\\n\\n\\n' references_markdown='\\n\\n## References\\n\\n⟨1⟩ https://microhealth.com/wp-content/uploads/2020/07/Frame.svg:  ![\\n⟨2⟩ http://microhealth.com/<https:/apps.apple.com/app/microhealth-hemophilia/id816380822>: iOS\\n⟨3⟩ http://microhealth.com/<https:/play.google.com/store/apps/details?id=com.microhealth.hemophilia>: Android\\n⟨4⟩ http://microhealth.com/<https:/apps.apple.com/app/scd-warrior/id1587853117>: iOS\\n⟨5⟩ http://microhealth.com/<https:/play.google.com/store/apps/details?id=com.scdwarrior>: Android\\n⟨6⟩ http://microhealth.com/<https:/microhealth.org/account/sign_up>: Hemophilia\\n⟨7⟩ http://microhealth.com/<https:/scdwarrior.com/hcp/>: Sickle Cell Disease\\n⟨8⟩ http://microhealth.com/<https:/microhealth.com/coming-soon/>: Blood Cancers: Coming Soon\\n⟨9⟩ http://microhealth.com/<https:/microhealth.com/products/adherence-outreach/>: Engagement & Adherence\\n⟨10⟩ http://microhealth.com/<https:/microhealth.com/products/research-studies/>: Research & Study Support\\n⟨11⟩ http://microhealth.com/<https:/microhealth.com/products/algorithms-interventions/>: AI Algorithms & Interventions\\n⟨12⟩ http://microhealth.com/<https:/microhealth.com/privacy/>: Privacy\\n⟨13⟩ http://microhealth.com/<https:/microhealth.com/about-us/>: About\\n⟨14⟩ http://microhealth.com/<https:/microhealth.com/science/>: Publications\\n⟨15⟩ http://microhealth.com/<https:/microhealth.com/microhealth-blog/>: Blog\\n⟨16⟩ https://microhealth.com/wp-content/themes/microhealth/assets/icons/chevron-down.svg: dropdown icon\\n⟨17⟩ http://microhealth.com/<#learn>: Learn More\\n⟨18⟩ http://microhealth.com/<http:/microhealth.com/terms-of-service/>: Terms of Service\\n⟨19⟩ http://microhealth.com/<http:/microhealth.com/privacy-notice/>: Privacy Notice\\n' fit_markdown='' fit_html=''",
  "generated_description": "**MicroHealth: Pioneering Digital Hematology**\n\nFounded in 2015 and hailing from New York as part of Y Combinator's Batch S15, MicroHealth is on a mission to innovate healthcare through digital therapeutics, particularly in the fields of hematology and oncology. They recognize that there are substantial unmet medical needs in these areas and aim to fill that gap with their advanced solutions.\n\n### How MicroHealth Works\n\nMicroHealth employs a three-pronged approach to revolutionize patient care:\n\n1. **Network Creation**: They establish relationships among doctors and patients to facilitate tracking, prediction, and disease prevention.\n2. **Validation**: They ensure their interventions are backed by clinical studies, achieving necessary regulatory clearances.\n3. **Commercialization**: The final step is turning their validated products into prescription digital therapeutics (DTx) available for patients.\n\n### Current Position\n\nMicroHealth has successfully positioned itself as a leader in the digital hematology landscape. Here are some key highlights from their journey:\n\n- **Extensive Network**: Their hemophilia network currently covers 33% of all patients and providers in the U.S.\n- **Competition**: They've outperformed over 20 competitors, including several Fortune 500 companies.\n- **Client Base**: Their influential clientele includes industry giants like Sanofi, Bayer, Novo Nordisk, Biogen, and Roche.\n\n### Offerings\n\nMicroHealth focuses on developing digital tools for blood condition management through their products:\n\n- **For Patients**: \n  - Hemophilia Management (available on [iOS](https://apps.apple.com/app/microhealth-hemophilia/id816380822) and [Android](https://play.google.com/store/apps/details?id=com.microhealth.hemophilia))\n  - Sickle Cell Disease Management (available on [iOS](https://apps.apple.com/app/scd-warrior/id1587853117) and [Android](https://play.google.com/store/apps/details?id=com.scdwarrior))\n  - Blood Cancers: Coming Soon\n\n- **For Providers**: Tools for managing conditions like Hemophilia and Sickle Cell Disease, with Blood Cancers coming soon.\n\n- **For Pharma**: Solutions focused on patient engagement, research support, and AI-driven interventions for better adherence and outcomes.\n\n### The Team\n\nMicroHealth operates with a compact team of 10 employees, spearheaded by dedicated professionals who are passionate about healthcare innovation. Notably, they have partnered with **nan**, enhancing their capabilities in delivering impactful health solutions.\n\n### Conclusion\n\nMicroHealth is setting a new standard in the digital hematology field, utilizing innovative technology to improve patient outcomes. Their strategic focus, robust network, and proven success against formidable competitors make them a noteworthy player in healthcare. For more information, visit [MicroHealth's website](http://microhealth.com). \n\nIn a landscape constantly evolving with digital health advancements, it's companies like MicroHealth that remind us of the potential technology holds in making healthcare more accessible and effective."
}